Bio-Gene Technology Market Cap

Bio-Gene Technology has a market cap or net worth of 11.29 million as of April 29, 2026. Its market cap has increased by 33.46% in one year.

Market Cap

11.29M

Enterprise Value

10.21M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.04

Market Cap Chart

Since November 29, 2017, Bio-Gene Technology's market cap has decreased from 20.89M to 11.29M, a decrease of -45.97%. That is a compound annual growth rate of -7.05%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	11.29M	60.87%
Dec 29, 2025	7.02M	-18.97%
Dec 30, 2024	8.66M	-28.33%
Dec 29, 2023	12.08M	-32.09%
Dec 29, 2022	17.79M	-48.81%
Dec 31, 2021	34.76M	61.59%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cambium Bio	12.30M
AdAlta	10.20M
Immuron	10.13M
Chimeric Therapeutics	8.84M
Tissue Repair	8.77M
Invex Therapeutics	8.27M
Biotron	8.11M
Neurotech International	15.81M

Market Cap Rankings